Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)

Study Identifier:
ENB-006-09
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete

Study Details

Medical Condition
  • Unmapped
Study Drug
  • Biological: asfotase alfa
Date
Sep 2009 - Jul 2010
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 5 - 12 Years
Requirements Information
Sex
Female & Male
Age
5 - 12 Years

Study Details

Medical Condition
  • Unmapped
Study Drug
  • Biological: asfotase alfa
Date
Sep 2009 - Jul 2010
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 5 - 12 Years years
Requirements Information

Protocol Summary

This clinical trial studied the safety and efficacy of asfotase alfa in children with HPP compared to a historical control group.

Trial Locations

Location
Status
Location
Shriners Hospital for Children
Saint Louis, Missouri, United States, 63131
Status
N/A
Location
The University of Manitoba Health Services Centre
Winnipeg, Manitoba, Canada, R3A 1S1
Status
N/A